Assay Specificity Optimization
Assay Specificity Optimization is a methodological framework in diagnostic monoclonal antibody development that enhances the selective binding of antibodies to target antigens by minimizing cross-reactivity with non-target molecules through systematic refinement of assay conditions and reagent composition.
88
Publications
3.3K
Citations
517
Authors
154
Institutions
Publications per year
2017–2026
17
88
1–5 of 88
517
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 517
154
Amgen (United States)
Thousand Oaks, United States
5 h-index
23 publications
403 citations
University of Massachusetts Chan Medical School
Worcester, United States
3 h-index
7 publications
288 citations
Eli Lilly (United States)
Indianapolis, United States
3 h-index
14 publications
553 citations
Jiangnan University
Wuxi, China
3 h-index
15 publications
350 citations

Uppsala University
Uppsala, Sweden
2 h-index
6 publications
217 citations

KTH Royal Institute of Technology
Stockholm, Sweden
2 h-index
21 publications
1.7K citations
Queen Elizabeth Hospital
Hong Kong, China
2 h-index
12 publications
232 citations

Broad Institute
Cambridge, United States
2 h-index
9 publications
1.5K citations
1–8 of 154
14 publications · 519 citations
12
h-index
Repository · 7 publications · 167 citations
7
h-index
5 publications · 100 citations
5
h-index
4 publications · 127 citations
4
h-index
BIO · 3 publications · 47 citations
3
h-index
1–5